PPIA and non-small cell lung carcinoma: Moreover, C28-treated non-small-cell lung cancer cell line 95C showed that metalloproteinase-9 activity is significantly decreased in a dose-dependent manner, which is a result of suppression of cyclophilin A induced by C28 [149].